18
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Treating the older hypertensive: beta-blocker or diuretic?

Pages 691-696 | Received 27 Aug 1985, Published online: 11 Aug 2008
 

Summary

Twenty-six ambulant elderly patients (age range 62 to 78 years) whose blood pressure control was inadequate with either beta-blocker or diuretic monotherapy were studied in a randomized, prospective double-blind comparison of atenolol (50 mg), amiloride (5 mg) with hydrochlorothiazide (50 mg), and these two treatments combined. Blood pressures were measured at least 24 hours after a single daily dose. The combined therapy was more effective in reducing lying (p<0.01) and standing (p<0.05) systolic blood pressure than either beta-blocker or diuretic alone. Combined therapy was more effective than diuretic on lying (p<0.05) or standing blood pressure (p<0.01). There was little difference in blood pressure control between beta-blocker and diuretic therapy. Side-effect complaints were similar on beta-blocker (5 complaints) and diuretic (7) and appeared to be additive on combined treatment (12). Diuretic treatment alone or in combination after the 1-month randomized periods produced shifts in some biochemical parameters (creatinine, urea, urate, sodium) in this older population of treated hypertensives, but clinically significant alteration in serum potassium levels was not seen.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.